Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC
Clinical trial NCT00997334 · COMPLETED
Trial details
- NCT number
- NCT00997334
- Sponsor
- David M. Jackman, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2015-05-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.